MARKET OPEN: Covid drug trial sets upbeat tone for local trading

MARKET OPEN: Covid drug trial sets upbeat tone for local trading
Paul McBeth
New Zealand’s stock market may be in for a positive start to the week after Wall Street closed stronger on Friday on optimism over a late-stage trial of the Remdesivir drug in treating covid-19. Investor optimism over the economic recovery from the covid-19 pandemic was stoked by drug company Gilead’s news that its antiviral remdesivir product significantly aided the recovery of severely ill patients. Australia’s Therapeutics Goods Administration gave provisional approval for remdesivir to be used in adults with severe covid symptoms. “Gi...

More Markets

Why Fonterra wants to churn out more butter
Primary Sector

Why Fonterra wants to churn out more butter

Other dairy processors have also invested in it.

Fletcher Building MD: ‘It hurts to make these cuts’
Property

Fletcher Building MD: ‘It hurts to make these cuts’

An emotional Andrew Reding says staff understand why the firm has to cut back.

Steel & Tube and Michael Hill navigate economic headwinds
Markets

Steel & Tube and Michael Hill navigate economic headwinds

Steel & Tube says recovery could take another 12 to 18 months. 

Kiwibank eyes a fairer fight with the Aussie big four
Finance

Kiwibank eyes a fairer fight with the Aussie big four

Kiwibank, partway through a $500m capital hike, sells growth and culture stories.